Abstract:Atrial natriuretic peptide (ANP), a small peptide consisting of 28 amino acids, has been applied in clinical treatment for heart failure, but it can encounter proteolytic degradation during its expression in host cells. Therefore, it is usually reported that ANP was expressed as a part of fusion protein. The aim of our study was to use an overexpression system to express the fusion protein REF-ANP and to optimize a purification method. First, Escherichia coli DH5alpha was transformed with constructed expression vector containing two tandem copies of ref-anp gene and the fusion protein REF-ANP was overexpressed in shaking flask culture. Subsequently, the inclusion bodies were purified with reverse phase chromatography and pooled fractions were lyophilized. After this step, REF-ANP can be solubilized under native conditions without urea. After cleavage reaction, the sample was subjected to size exclusion chromatography and then rANP was polished with reverse phase chromatography. The final purity of rANP was more than 98% and the recovery of rANP per liter of shaking flask culture was more than 3mg. Such methods as mass spectrometry, capillary isoelectrofocusing analysis, and N-terminal amino acid sequence were used to identify rANP. The capillary isoelectrofocusing analysis showed that the pI of ANP was about pH 9.7. In this study, an efficient refolding and purification process should make scaling-up procedures easier and more successful than earlier reports. Moreover, it is possible that the refolding and purification method along with the overexpression system described in this article may offer new ideas on optimizing expression and purification of other kinds of short peptides.

Fmoc Solid-phase Synthesis and Purification of Eptifibatide

A Novel Dextran-Grafted Tetrapeptide Resin for Antibody Purification

Scalable Preparation of Green C-terminal Amidation Peptide-Synthesis TAGs and the Optimized TAG-assisted Liquid-Phase Synthesis of Eptifibatide

An Optimized Scalable Fully Automated Solid-Phase Microwave-Assisted cGMP-Ready Process for the Preparation of Eptifibatide

An Immobilized Lipase with High Enantioselectivity in the Resolution of Racemic Ibuprofen

Solid-phase Synthesis of Bivalirudin and Its Method Optimization

Differential Mobility Spectrometry Followed by Tandem Mass Spectrometry with Multiple Ion Monitoring for Bioanalysis of Eptifibatide in Rat Plasma.

Method for solid phase synthesis liraglutide

Liquid-Phase Total Synthesis of Plecanatide Aided by Diphenylphosphinyloxyl Diphenyl Ketone (DDK) Derivatives

Overexpression and Purification of Recombinant Atrial Natriuretic Peptide Using Hybrid Fusion Protein REF-ANP in Escherichia Coli

Improved Tag-Assisted Liquid-Phase Peptide Synthesis: Application to the Synthesis of the Bradykinin Receptor Antagonist Icatibant Acetate

Linker-peptide-mediated one-step purification and immobilization of α-L-rhamnosidase from Bacteroides thetaiotaomicron for direct biotransformation from epimedin C to icariin

Preparation method of conopeptide Eb1.6

Immobilization of recombinant fibrinolytic enzyme rF II to polyurethane surface and fibrinolytic activity evaluation

Refolding and Purification of Erythrina Trypsin Inhibitor

Synthesis and Preparation of Cilengitide

Design, Preparation and in Vitro Bioactivity of Mono-PEGylated Recombinant Hirudin

Validated LC–MS–MS Method for Quantitative Determination of Batifiban in Human Plasma and Its Application to a Pharmacokinetic Study

Novel Biomimetic Affinity Ligands for Human Tissue Plasminogen Activator

Synthesis and Structure Characterization of Fmoc-L-Lys (Boc) -Gly-OH

Total Synthesis of Anticoagulant Pentasaccharide Fondaparinux.